Treatment of Bladder Spasms
Oxybutynin is the first-line pharmacological treatment for bladder spasms, with a typical dosing regimen of 5 mg 2-3 times daily, titrated as needed. 1, 2
First-Line Treatment Approach
Behavioral Modifications
- Implement bladder training and delayed voiding techniques to improve bladder capacity and reduce frequency and urgency 1, 3
- Perform pelvic floor muscle training to improve control over bladder function 1, 3
- Reduce fluid intake by approximately 25% to help decrease frequency and urgency 1, 3
- Avoid bladder irritants such as caffeine, alcohol, and spicy foods 1, 3
- Apply heat or cold over the bladder or perineum to help alleviate trigger points and reduce symptoms 1, 3
Pharmacological Management
- Oxybutynin is indicated for relief of symptoms of bladder instability, including urgency, frequency, urinary leakage, and urge incontinence 2
- Oxybutynin works by exerting a direct antispasmodic effect on smooth muscle and inhibiting the muscarinic action of acetylcholine 2
- Alternative anticholinergic options if oxybutynin is not tolerated include:
Management of Side Effects and Special Considerations
- Common anticholinergic side effects include dry mouth, constipation, dry eyes, blurred vision, and cognitive effects 5, 1
- Strategies to manage side effects include:
- Switching to a lower dose
- Using extended-release formulations
- Trying transdermal delivery systems 1
- Anticholinergics are contraindicated in:
- Use anticholinergics with caution in patients with post-void residual (PVR) >250-300 mL 1, 3
Second-Line and Advanced Treatment Options
- For inadequate response after 8-12 weeks of optimized pharmacotherapy, consider:
Special Clinical Scenarios
Post-operative Bladder Spasms
- Tolterodine (2 mg twice daily) has been shown effective for bladder spasms caused by indwelling catheters after prostate operations 4
- In one study, after 72 hours of treatment, bladder spasm was alleviated totally in 54.9% of patients, partially in 36.6%, and unrelieved in 8.5% 4
Malignancy-related Bladder Spasms
- For cancer-related bladder spasms refractory to standard treatments, lumbar sympathetic blockade at L4 may be considered 7
Neurogenic Bladder with Severe Spasms
- In patients with spinal cord injury and severe bladder spasms, intrathecal baclofen may be effective when other treatments fail 8
Monitoring and Follow-up
- Allow adequate trial periods (8-12 weeks) to determine efficacy before changing therapies 1
- Educate patients that treatment effects are typically maintained only as long as therapy is continued 1
- Post-void residual monitoring may be necessary in patients at risk for urinary retention, particularly before and after botulinum toxin therapy 1, 3
- Periodically reassess efficacy of treatment and discontinue ineffective treatments 3